Erythrina Alkaloids: An Updated Review with Neurological Perspective.
Last updated: 03 Jan 2025
10.21608/aps.2023.207482.1119
Erythrina, alkaloid, Alzheimer’s disease, anxiolytic, Anticonvulsant
Ahmed
Salem
M.
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
ahmed.m.salim@pharma.asu.edu.eg
Nada
Mostafa
M.
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
nadamostafa@pharma.asu.edu.eg
Cairo
0000-0003-1602-2725
Eman
Al-Sayed
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
em_alsayed@pharma.asu.edu.eg
0000-0001-7869-2009
Abdel-Nasser
Singab
B.
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt. , Center for Drug Discovery Research and Development, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
dean@pharma.asu.edu.eg
7
1
40766
2023-06-01
2023-04-27
2023-06-01
171
199
2356-8380
2356-8399
https://aps.journals.ekb.eg/article_308016.html
https://aps.journals.ekb.eg/service?article_code=308016
308,016
Review Article
658
Journal
Archives of Pharmaceutical Sciences Ain Shams University
https://aps.journals.ekb.eg/
Erythrina Alkaloids: An Updated Review with Neurological Perspective.
Details
Type
Article
Created At
24 Dec 2024